Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

2014 BRFSS Asthma Call-Back Survey Prevalence Tables


TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2014

State/Territory Current Active
Sample
size±		 % SE§ 95% CI† Sample
size		 % SE 95% CI
Alabama 213 48.1 8.5 (31.4 – 64.8) 228 47.1 8.0 (31.4 – 62.8)
Florida 214 51.3 6.3 (39.0 – 63.6) 229 50.5 6.3 (38.2 – 62.8)
Kansas 264 50.2 6.4 (37.7 – 62.7) 278 50.3 6.3 (38.0 – 62.6)
Louisiana 93 68.2 9.1 (50.4 – 86.0) 106 57.0 10.5 (36.4 – 77.6)
Massachusetts 139 62.1 7.8 (46.8 – 77.4) 141 63.0 7.7 (47.9 – 78.1)
5 state total 923 54.6 3.8 (47.2 – 62.0) 982 53.3 3.8 (45.9 – 60.7)
Median   51.3       50.5    
Range   48.1-68.2       47.1-63.0    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline sample size excludes “DK/Refused”

§ Standard error

† Confidence interval

TOP